Spring in Quebec marks an important turning point for the skin: after months of dry, cold air that dries out and weakens the skin barrier, the return of heat, humidity and sunshine radically alters the skin environment. This seasonal transition can trigger or aggravate a number of common dermatological conditions - acne flare-ups linked to the increase in seborrhea with the heat, rosacea flare-ups triggered by the sun and temperature variations, seasonal hair loss more pronounced in autumn but whose triggers often date back to spring and summer. These conditions are common, often poorly managed by self-medication, and respond well to appropriate medical treatment.
Clinique Omicron offers medical consultations for common skin conditions at several of its branches in Quebec, with referral to a dermatologist or physician specializing in aesthetic medicine when the clinical situation requires it. This article outlines the mechanisms of the main spring skin disorders, the treatments available, and the signs that warrant immediate medical consultation.
Springtime acne: why outbreaks worsen and how to treat them
Acne vulgaris is the most widespread dermatosis, affecting up to 85 % of teenagers and a growing proportion of adults - particularly women between the ages of 25 and 40, for whom hormonal acne represents a significant source of psychological distress and reduced quality of life. In spring, several factors contribute to the worsening of acne: heat increases sebum production and favours the proliferation of Cutibacterium acnes in clogged hair follicles, perspiration aggravates pore clogging, and sun exposure - while temporarily improving skin appearance through its anti-inflammatory effect - often leads to a rebound of comedonal and inflammatory acne when exposure ceases, a phenomenon known as ’summer acne«.
First-line topical treatments include retinoids - tretinoin, adapalene - which normalize follicular keratinization and prevent comedo formation, benzoyl peroxide which has an antibacterial and anti-inflammatory effect, and topical antibiotics - clindamycin - in combination with benzoyl peroxide to limit bacterial resistance. For moderate to severe acne or acne resistant to topical treatments, oral antibiotics - doxycycline -, combined oral contraceptives in women - particularly those with an antiandrogenic effect - and, in the case of severe nodulocystic acne, oral isotretinoin (Accutane) are the reference treatment options. Isotretinoin is a potent teratogen, requiring effective contraception and rigorous medical monitoring. Daily sun protection is essential with retinoids and isotretinoin, which increase skin photosensitivity.
Rosacea: spring triggers and medical management
Rosacea is a chronic inflammatory dermatosis mainly affecting the face - nose, cheeks, forehead, chin - characterized by persistent or episodic redness, telangiectasias (small visible dilated vessels), acne-like papules and pustules, and sometimes hyperplasia of the nasal sebaceous glands (rhinophyma). It affects around 5 % of the adult population, with a predilection for light phototypes and people of Northern European descent. Spring is a typical flare-up period: the sun is the most frequently reported trigger, followed by sudden thermal variations - moving from a warm environment to a cold spring and vice-versa - physical exercise, alcohol, spices, and emotional stress.
Rosacea management combines protective measures and avoidance of triggers with targeted medical treatments. Daily sun protection with a mineral sunscreen - zinc oxide or titanium dioxide, less irritating than chemical filters for reactive skin - is fundamental. Reference topical treatments include metronidazole gel or cream - effective on papulo-pustules - azelaic acid, and ivermectin cream - particularly effective for papulo-pustular forms by targeting Demodex folliculorum, a follicular mite over-represented in rosacea. Brimonidine gel and oxymetazoline cream act on persistent redness by inducing cutaneous vasoconstriction. Moderate to severe forms benefit from oral doxycycline in sub-antimicrobial anti-inflammatory doses. Vascular laser and intense pulsed light (IPL) are effective options for reducing telangiectasia and persistent redness, available in aesthetic medicine.
Hair loss: telogen effluvium, androgenic alopecia and medical causes
Hair loss - alopecia - is a frequent reason for medical consultation and a source of considerable anxiety, particularly for women. Autumn is the period of greatest seasonal hair loss in human beings - this physiological phenomenon results from a circadian synchronization of follicular cycles, with many follicles entering the telogen phase (resting) in spring and effective hair loss 3 to 6 months later, in autumn. Moderate seasonal loss is therefore normal and does not require medical attention. On the other hand, a sudden, diffuse loss occurring 2 to 4 months after a triggering event - intense stress, febrile illness, surgery, childbirth (post-partum effluvium), restrictive diet, martial or thyroid deficiency - corresponds to a reactive telogen effluvium that merits medical evaluation to identify and correct the cause.
Androgenetic alopecia - or male or female pattern alopecia - is the most common form of chronic, progressive hair loss, affecting 50 % of men before the age of 50 and a significant proportion of women after the menopause. It results from the genetic sensitivity of hair follicles to dihydrotestosterone (DHT). In men, it typically manifests itself as a receding forehead and thinning vertex; in women, as a diffuse thinning of the vertex with preservation of the hairline. Medical treatments available in Canada include topical minoxidil - over-the-counter, effective in slowing hair loss and modestly stimulating regrowth - and oral finasteride in men (a 5-alpha-reductase inhibitor, contraindicated in women of childbearing age). A medical consultation is needed to establish the diagnosis, rule out treatable causes with a targeted blood test (TSH, ferritin, FSH, free testosterone), and discuss treatment options.
Frequently asked questions about spring skin health
Does sunscreen make acne worse? How to choose sun protection for acne-prone skin?
It's a legitimate and frequent concern - some sunscreen formulations, particularly those based on heavy mineral oils or occlusive filters, can actually worsen acne by clogging pores. However, sun protection remains essential for people undergoing anti-acne treatment - retinoids, doxycycline, isotretinoin - which considerably increase photosensitivity, and to prevent post-inflammatory hyperpigmentation that leaves persistent dark spots after pimples. The solution is to choose a formulation suited to acne-prone skin: non-comedogenic gel, fluid or serum textures are preferred to thick creams; mineral filters - zinc oxide, titanium dioxide - are generally better tolerated than chemical filters for acne-prone skin; dermatologically tested formulations bearing the words «non-comedogenic» on the packaging are more suitable. Many brands offer sun creams specifically formulated for acne-prone skin - consult a doctor or pharmacist for personalized recommendations based on your skin type and current treatment.
Is my post-partum hair loss normal and will it stop?
Post-partum telogen effluvium is an extremely common and normal condition, affecting the vast majority of women in the 2-6 months following childbirth. During pregnancy, high estrogen levels prolong the anagen (growth) phase of hair follicles, reducing normal hair loss and giving the impression of thicker, more abundant hair. After childbirth, the sudden drop in estrogen leads to a synchronized entry of many follicles into the telogen (resting) phase, with diffuse and sometimes impressive hair loss 2 to 4 months later. This loss is temporary, and hair generally grows back spontaneously over a period of 6 to 12 months without treatment. It is important, however, to ensure that there is no iron deficiency - common in the post-partum period - or thyroid deficiency, which can aggravate and prolong effluvium. If hair loss is particularly severe, if it persists beyond 12 months post-partum, or if you notice persistent thinning at the vertex rather than diffuse hair loss, a medical consultation with a biological check-up is recommended.
At what age can you start using tretinoin, and what are the risks?
Topical tretinoin is a prescription retinoid used for two main indications: the treatment of acne and the correction of signs of skin aging - fine wrinkles, pigment spots, uneven texture. For acne, it can be prescribed as early as adolescence - generally from age 12 - under medical supervision. For aging, its use is typically initiated in the late twenties or thirties as a preventive-corrective measure. The most common adverse effects at the start of treatment are skin dryness, redness, flaking and transient irritation - the initial «purge», which corresponds to the acceleration of cell renewal and may temporarily cause more pimples to appear in the first few weeks of acne use. These effects diminish with skin adaptation and appropriate use: start with a low frequency of application (2 to 3 times a week) and a low concentration (0.025 %), increase gradually, apply in the evening to dry skin, and use a moisturizing cream in the morning combined with systematic sun protection. Tretinoin is formally contraindicated during pregnancy and breastfeeding due to the teratogenic risk of systemic retinoids, although cutaneous absorption of topical tretinoin is very low.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.
